Blog
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Breakthrough findings were presented at the 2022 ASCO Annual Meeting
June 17, 2022
Menu
Breakthrough findings were presented at the 2022 ASCO Annual Meeting
It is a pity that non integrating lentiviral vectors are
In a recent study, a team of researchers used a
With a $17 million grant, UCSF Benioff Children’s Hospital in
The FDA has granted accelerated designation to PRGN-3006 for the
Mucopolysaccharidosis I is caused by mutations in the gene for
In the process of engineering CAR T cells, if the
Many people are excluded from CAR T cell-based treatments because
CAR T-cell therapy and antibody treatments are two types of
